• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.54% Nasdaq Down1.52%

    The Spectranetics Corporation (SPNC)

    -NasdaqGS
    34.72 Up 0.21(0.61%) Apr 17, 4:00PM EDT
    |After Hours : 34.72 Down 0.00 (0.01%) Apr 17, 4:22PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    The Spectranetics Corporation
    9965 Federal Drive
    Colorado Springs, CO 80921
    United States - Map
    Phone: 719-633-8333
    Fax: 719-447-2022
    Website: http://www.spectranetics.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Appliances & Equipment
    Full Time Employees:753

    Business Summary 

    The Spectranetics Corporation, together with its subsidiaries, develops, manufactures, markets, and distributes single-use medical devices used in minimally invasive procedures in the cardiovascular system. Its products are used to cross, prepare, and treat arterial blockages in the legs and heart, and to remove pacemaker and defibrillator cardiac leads. The company's vascular intervention product line includes crossing solutions, which support catheters to facilitate crossing of peripheral and coronary arterial blockages, and retrograde access and guidewire retrieval devices used in the treatment of peripheral arterial blockages, including chronic total occlusions; peripheral atherectomy, a range of laser catheters for ablation of blockages in arteries above and below the knee; and coronary atherectomy and thrombectomy, which are aspiration for the treatment of blockages in the heart. Its primary crossing catheters include Quick-Cross, Quick-Cross Select, and Quick-Cross Extreme; the ELCA Laser Ablation Catheter for coronary atherectomy; and QuickCat aspiration catheter for thrombus management. The company's lead management product line comprises excimer laser sheaths, non-laser mechanical sheaths, and cardiac lead management accessories, such as Spectranetics Laser Sheath, and Lead Locking Device for the removal of pacemaker and defibrillator cardiac leads. It also offers the Stellarex DCB platform that is designed to treat peripheral arterial disease. The company sells its products in the United States, Canada, Europe, the Middle East, the Asia Pacific, Latin America, and Puerto Rico. The Spectranetics Corporation was founded in 1984 and is headquartered in Colorado Springs, Colorado.

    Key Statistics


    Company Websites 
    Home Page
    Investor Relations
    Search Yahoo! for:
    More on The Spectranetics Corporation

    Corporate Governance 
    The Spectranetics Corporation’s ISS Governance QuickScore as of Apr 1, 2015 is 2. The pillar scores are Audit: 2; Board: 1; Shareholder Rights: 6; Compensation: 1.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Scott William Drake , 47
    Chief Exec. Officer, Pres and Director
    1.14M0.00
    Mr. Guy A. Childs , 49
    Chief Financial Officer and VP
    552.00K187.00K
    Mr. Shahriar Matin , 40
    Chief Operating Officer
    466.00K0.00
    Mr. Paul Gardon , 49
    Sr. VP and Gen. Counsel
    413.00K0.00
    Ms. Kimberly McIntosh Bridges R.N, B.S.N,
    Sr. VP of Sales & Marketing for Vascular Intervention
    237.00K0.00
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders